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ABSTRACT Forms of the DNA double helix containing
non-Watson-Crick base-pairing have been discovered recently
based on x-ray diffraction analysis of quinoxaline antibi-
otic-oligonucleotide complexes. In an effort to find evidence for
Hoogsteen base-pairing at quinoxaline-binding sites in solu-
tion, chemical "footprinting" (differential cleavage reactivity)
of echinomycin bound to DNA restriction fragments was
examined. We report that purines (A>G) in the first and/or
fourth base-pair positions of occupied echinomycin-binding
sites are hyperreactive to diethyl pyrocarbonate. The corre-
spondence of the solid-state data and the sites of diethyl
pyrocarbonate hyperreactivity suggests that diethyl pyrocar-
bonate may be a sensitive reagent for the detection ofHoogsteen
base-pairing in solution. Moreover, a 12-base-pair segment of
alternating A-T DNA, which is 6 base pairs away from the
nearest strong echinomycin-binding site, is also hyperreactive
to diethyl pyrocarbonate in the presence of echinomycin. This
hyperreactive segment may be an altered form of right-handed
DNA that is entirely Hoogsteen base-paired.
X-ray analyses of triostin A and echinomycin complexed to
the hexanucleotide duplex d(CGTACG)2 (1, 2) and triostin A
complexed to the octanucleotide duplex d(GCGTACGC)2 (3)
show that these quinoxaline bisintercalators bracket a 5' C-G
3' dinucleotide and induce Hoogsteen base-pairing (4) of the
AT and G-C base pairs flanking the central Watson-Crick
base pairs (5) (Fig. 1). In solution, "footprinting" (differential
cleavage reactivity) on DNA restriction fragments reveals
that echinomycin has a binding-site size of 4 base pairs (bp)
(6). The strong binding sites of echinomycin and triostin A
contain the central 2-bp sequence 5' C-G 3' with a preference
in the first and fourth position for A-T base pairs, though not
excluding G-C base pairs (6-8). The sequence 5' ACGC 3'
contained in one of the solid-state studies (3) is a binding site
for echinomycin in solution (ref. 6; Fig. 1). Since the
oligonucleotides used in the x-ray crystal studies are small
and the bisintercalators are bound at or near the ends of the
DNA duplexes, the question arises whether such drug-
induced Hoogsteen base-pairing found in the solid state
would be observed in solution within a large fragment of
DNA at 25°C and pH 7.4.
Diethyl pyrocarbonate, (EtOOC)20, is a sensitive reagent
for the detection of left-handed Z-DNA (9, 10) and cruciform
loops (11, 12). Z-DNA hyperreactivity toward (EtOOC)20
relies on the exposure ofthe N-7 atom of purines adopting the
syn conformation, which leads to a chemically modified base
(13, 14) and strand scission upon heating (90°C) in the
presence of piperidine; thus, syn purines within Z-DNA
regions can be identified at nucleotide resolution by sequenc-
ing gel techniques (9, 10). Right-handed Hoogsteen base-
paired DNA also requires purines to adopt the syn confor-
mation, and this form ofDNA would expose the N-1 and N-3
atoms of purines in the major groove (Fig. 1). Therefore,
purines rearranging from Watson-Crick to Hoogsteen base-
pairing in right-handed DNA might also display differential
reactivity to (EtOOC)20. If this were the case, (EtOOC)20/
piperidine treatment of DNA in the presence of quinoxaline
antibiotics, followed by analysis of the cleavage sites on a
high-resolution sequencing gel, would allow mapping of
Hoogsteen base pairs at nucleotide resolution. A combina-
tion of methidiumpropyl-EDTA-Fe(II) MPE.Fe(II) footprint-
ing and (EtOOC)20 hyperreactivity studies would then define
the relationship between quinoxaline antibiotic binding sites
and the sites of Hoogsteen base-pairing.
Echinomycin binding sites were determined by MPE-Fe(II)
footprinting (6, 15) on a 628-bp restriction fragment. The
reactivity of purines toward (EtOOC)20 was examined on the
same restriction fragment in the presence of identical con-
centrations of echinomycin. In the absence of echinomycin,
(EtOOC)20 does not react with the 628-bp fragment ofDNA
to a significant extent under the reaction conditions chosen.
However, at low binding levels of echinomycin, we find
hyperreactivity to (EtOOC)20 at adenine and guanine bases
in the first and/or fourth base-pair positions of the echino-
mycin binding sites assigned from the MPE.Fe(II) footprint-
ing at 37°C and pH 7.4. In addition, we find that the adenines
in a 12-bp segment of A-T DNA that is 6 bp distal to the
nearest strong echinomycin binding site become increasingly
reactive toward (EtOOC)20 as the concentration of
echinomycin increases.
MATERIALS AND METHODS
Dithiothreitol, calf alkaline phosphatase, T4 polynucleotide
kinase, restriction endonucleases, and the Klenow fragment
of Escherichia coli DNA polymerase I were purchased from
Boehringer Mannheim; T4 DNA ligase, from New England
Biolabs; Et2C203, from Aldrich; and bovine pancreatic
DNase I, from Worthington. Echinomycin was obtained from
the Natural Products Branch, Division of Cancer Treatment,
National Cancer Institute, and concentrations were deter-
mined spectrophotometrically by using 6325 = 11,500
M-' cm-1 (7). Buffers were of two types: 10 mM Tris, pH
7.4/50 mM NaCl (TN buffer) and 50 mM sodium cacodylate,
pH 7.2/10 mM KCl/10 mM MgCl2/5 mM CaCl2 (CKMC
buffer).
Plasmid Construction. Two complementary oligonucleo-
tides, 1 (5' AGCTTATATATATATAAAAAGGGGGGGG-
GGTCGATAG) and 2 (5' GATCCTATCGACCCCCCCCC-
CTTTTTATATATATATA), were synthesized on an auto-
mated DNA synthesizer using phosphoramidite chemistry
(16, 17). Purification of the oligonucleotides via gel electro-
phoresis was followed by 5' phosphorylation with ATP and
T4 kinase. Hybridization of oligonucleotides 1 and 2 yielded
Abbreviation: MPE-Fe(II), methidiumpropyl-EDTA-Fe(II).
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thymus DNA was incubated for 15 min at 370C. Next, 2 Al of
80 ,uM MPE*Fe(II)/160 AM Fe(NH4)2(SO4)2 solution was
added, and the mixture was mixed and allowed to equilibrate
another 15 mm at 370C. DNA strand scission was initiated by
adding 2 Al of a freshly prepared 40 mM dithiothreitol
solution. Cleavage at 370C was terminated after 20 min by
freezing on dry 'ice, followed by two precipitations with
ethanol. The final concentrations in the 20-1.l reaction mix-
ture were 400 AM DNA base pairs; 10 mM Tris (pH 7.4); 50
mM NaCl; 8 AM MPEFe(II); 16 puM Fe(NH4)2(SO4)2; 10%(vol/vol) methanol; 0, 12.5, 25, 50, or 100 jAM echinomycin;
and 4 mM dithiothreitol.
DNase I Footprinting. A 16-plI solution of buffered 32P-end-
labeled restriction fragment, echinomycin (dissolved in meth-
anol), and sonicated deproteinized calf thymus DNA was
incubated for 15 min at 370C. Next, 4 A1l of dithiothreitol (1
mM)/DNase I (0.33 ,g/ml) was added, mixed, and allowed
to stand for 2 min at room temperature. DNase I digestion
was terminated by addition of 5 1LA of 3 M NH4OAc/0.25 M
EDTA and 150/l ofcold ethanol. The reaction mixtures were
then precipitated with ethanol and washed. The final con-
centrations in the 20-/.l DNase I digestion mixtures (before
the stop solution) were 400 ,M DNA base pairs, 50 mM
- + i -+ cc ++ + e 4- + 4 + +
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FIG. 1. (Upper) Diagram of the complex between a quinoxaline
bisintercalator and a right-handed DNA duplex similar to that shown
in ref. 3. The quinoxaline rings are represented by dark bars and the
cyclic depsipeptide backbone is drawn as an oval. The first and
fourth base pairs are Hoogsteen-paired and the central COG is
Watson-Crick-paired. (Lower) Schematic drawings show TEA and
COG Hoogsteen base pairs. The C-G Hoogsteen base-pairing requires
a protonated cytosine. b AD a As
a short duplex possessing cohesive BamHI and HindIII ends,
which was ligated into the 4.0-kilobase (kb) BamHI-HindIII
fragment of pBR322. The resulting ligation mixture was used
to transform E. coli strain HB101 by the CaCl2 procedure
(18). Recombinant clones were selected for ampicillin resist-
ance and tetracycline sensitivity, as deletion of the small
BamT{I-HindIII fragment of pBR322 disrupts the gene re-
sponsible for tetracycline resistance (19). Milligram quanti-
ties of the recombinant plasmid pDMG10 (4054 bp) were
isolated by standard procedures (20). Restriction mapping
and chemical sequencing confirmed the construction. A
uniquely labeled 628-bp EcoRI-Bgi I restriction fragment
containing the inserted duplex was obtained by linearizing
pDMG10 with EcoRI, labeling as described (6), and cleaving
with Bgl I. Electrophoresis through 1.5% low-melting
agarose separated the 628-bp fragment from other digest
products. The desired DNA was then extracted from the
agarose and precipitated with ethanol.
MPE-Fe(II) Footprinting. A buffered 16-lA solution con-
taining purified end-labeled restriction fragment, echinomy-
cin (dissolved in methanol), and sonicated deproteinized calf
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FIG. 2. Autoradiogram of 5' (lanes 1-13) and 3' (lanes 14-26)
32P-end-labeled DNA restriction fragments. Lanes: 1 and 16, intact
DNA; 2 and 17, MPEEFe(II)-mediated cleavage of DNA in the
absence (-) of echinomycin; 3-6 and 18-21, MPEFe(II)-mediated
cleavage of DNA in the presence (+) of echinomycin at 12.5, 25, 50,
and 100 ,uM, respectively; 7 and 22, (EtOOC)20/piperidine cleavage
ofDNA in the absence ofechinomycin; 8-11 and 23-26, (EtOOC)20/
piperidine cleavage ofDNA in the presence of echinomycin at 12.5,
25, 50, and 100 AM, respectively; 12 and 14, Maxam-Gilbert
chemical-sequencing guanine-specific reaction; 13 and 15, Maxam-
Gilbert chemical-sequencing purine-specific reaction. The gel was
scanned from the bottom to the arrow (at left). Brackets denote the
5' (T-A)6 3' segment hyperreactive to (EtOOC)20.
Biochemistry: Mendel and Dervan
....
0
-
-
do 4w T
912 Biochemistry: Mendel and Dervan Proc. Natl. Acad. Sci. USA 84 (1987)
sodium cacodylate (pH 7.2), 10 mM KCl, 10 mM MgCl2, 5 and 1 Al of (EtOOC)20 was added. The mixture was then
mM CaCl2, 10% (vol/vol) methanol, 66 ng of DNase I per ml, incubated for 15 min at room temperature with occasional
200 ,uM dithiothreitol, and 0 or 100 ptM echinomycin. mixing. The concentrations of DNA, buffer, methanol, and
(EtOOC)20 Footprinting. A buffered 19-,l solution of echinomycin were identical to those in the MPE Fe(II) or
labeled restriction fragment, echinomycin (dissolved in meth- DNase I protocols above. (EtOOC)20 modification of the
anol), and sonicated deproteinized calf thymus DNA was DNA was terminated by two precipitations with ethanol,
incubated for 15 min at 37°C. The mixture was cooled to 0°C, followed by vacuum-drying. The resulting pellet was resus-
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FIG. 3. (A-D) MPE-Fe(II)-mediated DNA cleavage-inhibition patterns in the presence of echinomycin at 12.5, 25, 50, and 100 ,uM,
respectively, bound to 100 bp of the 628-bp fragment, as determined by densitometry from the autoradiogram in Fig. 2 (lanes 3-6 and 18-21).(E-H) (EtOOC)20/piperidine cleavage patterns in the presence of echinomycin at 12.5, 25, 50, and 100 uM, respectively, bound to the same
100 bp of DNA, as determined by densitometry-from the autoradiogram in Fig. 2 (lanes 8-11 and 23-26). MPE-Fe(II) cleavage-inhibition patterns(A-D) are shown as histograms with the height proportional to the reduction ofcleavage at each nucleotide compared with MPEPFe(II)-mediated
cleavage of unprotected DNA. (EtOOC)20 cleavage patterns (E-H) are shown as arrows, with the height proportional to the enhancement of
cleavage at each nucleotide compared with the (EtOOC)20/piperidine cleavage of unbound DNA. The scale at the bottom corresponds to the
first 5' thymidine in the EcoRI site of plasmid pDMG10, defined as position 1. Boxes are the assigned echinomycin binding sites based on the
model in refs. 6 and 15.
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pended in 30 Al of 1 M piperidine, heated for 10 min at 900C,
and lyophilized twice. The (EtOOC)20 control contained
methanol (10%, vol/vol) and was subjected to the identical
piperidine workup as were the samples containing echino-
mycin.
Sequencing Gel Electrophoresis. Base-specific cleavage
reactions were performed as described by Maxam and Gilbert
(21). Samples from (EtOOC)20, MPE-Fe(II), or DNase I
cleavage protocols were resuspended in 90% formamide
buffer and heat-denatured for 2 min at 90°C. The denatured
samples were then loaded onto an 8% 1:19 crosslinked
polyacrylamide gel containing 50% (wt/vol) urea. The 40 x
34 cm wedge gel was 0.2 mm thick at the comb and 0.6 mm
thick at the base. Electrophoresis was carried out at 1200 V
for 4 hr. The gel was dried and then autoradiographed without
intensification for 4 days at -70°C with Kodak X-Omat AR
film. Densitometric analysis of the autoradiogram was car-
ried out with an LKB Ultroscan XL 2222 laser densitometer.
RESULTS
Purines Proximal to Echinomycin Binding Sites Are flyper-
reactive to (FtOOC)20. The patterns of MPE-Fe(II)- and(EtOOC)20-mediated DNA cleavage of the 5' and 3' 32P-end-
labeled 628-bp EcoRI-Bgl restriction fragment of plasmid
DNA were visualized on the autoradiogram of a high-
resolution gel (Fig. 2). In the absence of echinomycin, we
observe an even DNA cleavage pattern with MPE-Fe(II)
(control lanes 2 and 17) and very slight cleavage of purines
with (EtOOC)20/piperidine (control lanes 7 and 22). In the
presence of echinomycin, the cleavage patterns for MPE-Fe-
(II) and (EtOOC)20/piperidine differed significantly from
those of controls (Fig. 2, lanes 3-6 and 18-21 vs. 8-11 and
23-26). Echinomycin at 12.5-100 ,uM protected DNA (400
A.M in base pairs) from cleavage mediated by MPE-Fe(II).
The echinomycin binding sites on 100 bp of this restriction
fragment, assigned from diminished cleavage with MPE-Fe-
(II), were (5'-3') TCGA, TCGA, TCCT, ACGCCGGACGC,
TCGT, CCGG, TCACCGG, GCCA, AGGT, andGCGG. In the
presence of echinomycin, hyperreactivity toward (EtOOC)20
occurred at purines (A > G) flanking a central dinucleotide,
(5'-3') C-G > C-C or G-G at these same sites (Fig. 3). In data
not shown, the quinoxaline antibiotic triostin A showed
similar behavior. However, unlike echinomycin and triostin
A, other small DNA binding molecules such as the intercala-
tor-groove binder actinomycin D or the groove binder
distamycin A did not produce purine hyperreactivity toward
(EtOOC)20.
Purines Distal to Strong Echinomycin Sites Are Hyperreac-
tive to (EtOOC)20. A 12-bp site with the sequence 5'
TATATATATATA 3', which was not protected from MPE-Fe-
(II)-mediated cleavage in the presence of echinomycin and is
6 bp away from the nearest strong echinomycin binding site,
5' TCGA 3', became increasingly reactive toward (EtOOC)20
as the echinomycin concentration was increased. The pattern
of adenine-(EtOOC)2O hyperreactivity within this region
was asymmetric to the 3' side and extended over 10 bp on
both strands (bracketed region in Figs. 2 and 4). Densito-
metric analysis of both MPE-Fe(II)- and (EtOOC)20-modi-
fied cleavage patterns in the presence of echinomycin are
presented in Fig. 3.
DNase I and MPE Fe(I) Cleave the 5' (T-A)6 3' Site Distal
to a Strongly Bound Echinomycin. In the presence of 100 ,M
echinomycin, the enzyme DNase I showed broad regions of
cleavage inhibition on the 628-bp DNA restriction fragment
at locations where MPE.Fe(II)-mediated cleavage inhibition
patterns revealed several discrete echinomycin binding sites
(Fig. 4). However, as with MPE-Fe(II), DNase I cleaved the
5' (T-A)6 3' site in the presence of 100 ,uM echinomycin with
an efficiency comparable to that found in the absence of
echinomycin (Fig. 4, compare lanes 15 and 16 with 17 and 18).
Moreover, the 5' (T-A)6 3' site is not sensitive to cleavage by
nuclease S1 (data not shown), which is specific for single-
stranded DNA (22).
DISCUSSION
Hoogsteen Base-Pairing Proximal to Echinomycin Sites.(EtOOC)20 hyperreactivity of purines in the first and/or
fourth positions of the echinomycin binding sites, indepen-
dently determined by MPE-Fe(II) footprinting, suggests that
the WatsonCrick-to-Hoogsteen base pair structural reorga-
nization ofDNA that was discovered by Rich and coworkers
in the x-ray crystal structures of quinoxaline antibiotic-
oligonucleotide complexes may also exist in solution (25TC,
p11 7.4). With (EtOOC)20, cleavage enhancement at purines
in the first and/or fourth positions of echinomycin sites is
observed on a sequencing gel, which corresponds to cleavage
inhibition at sites 4 bp in size observed with MPE-Fe(II) (Fig.
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FIG. 4. Autoradiogram of 5' (lanes 1, 3, 5, 7, 9, 11, 12, 15, 17, 19,
and 21) and 3' (lanes 2, 4, 6, 8, 10, 13, 14, 16, 18, 20, and 22)32P-end-labeled DNA restriction fragments. Lanes: 1 and 2, intact
buffered DNA; 3 and 4, MPE.Fe(II)-mediated cleavage of DNA in
the absence (-) of echinomycin; 5 and 6, MPE.Fe(II)-mediated
cleavage ofDNA in the presence (+) of 100 ,uM echinomycin; 7 and
8, (EtOOC)20/piperidine cleavage ofDNA in the presence of 100 AM
echinomycin; 9 and 10, (EtOOC)20/piperidine cleavage of DNA in
the absence of echinomycin; 11-14, Maxam-Gilbert chemical se-
quencing G- and G+A-specific reactions; 15 and 16, DNase I
cleavage of DNA in the absence of echinomycin; 17 and 18, DNase
I cleavage of DNA in the presence of 100 ,uM echinomycin; 19 and
20, (EtOOC)20/piperidine cleavage of DNA in the presence of 100
.iM echinomycin; 21 and 22, (EtOOC)20/piperidine cleavage of
DNA in the absence of echinomycin. Reactions in lanes 1-10 were
performed in TN buffer, and in lanes 15-22 in CKMC buffer.
Brackets denote the 5' (T-A)6 3' site hyperreactive to (EtOOC)20.
do
914 Biochemistry: Mendel and Dervan
3). Because (EtOOC)20 detects bound quinoxaline antibiot-
ics at nucleotide resolution, (EtOOC)20 can be considered
the preferred reagent for footprinting DNA-bound quinoxa-
line antibiotics, especially in cases where several binding
sites are clustered or where they overlap. The finer precision
of (EtOOC)20 relative to MPE-Fe(II) is accompanied by
greater sensitivity of the former reagent. This is probably
because MPE-Fe(II) competes with echinomycin for binding
sites whereas (EtOOC)20 does not. The relative reactivity of
adenine versus guanine may be due to the ease with which
adenine adopts the syn conformation, to the intrinsic reac-
tivities of adenine and guanine toward (Et200C)20 in Hoog-
steen base-paired DNA, or to some combination ofboth. One
explanation for purine hyperreactivity is that right-handed
Hoogsteen DNA exposes nucleophilic purine N-1 atoms,
making them available for reaction with (EtOOC)20 (23-25).
Hoogsteen Base-Pairing Distal to Echinomycin Binding
Sites. As noted above, adenines within the (T-A)6 segment
show enhanced reactivity with (EtOOC)20 in the presence of
echinomycin. This suggests that this segment can adopt a
conformation that is non-B-form, since B-DNA is relatively
unreactive to (EtOOC)20. The fact that cleavage of the 5'
(T-A)6 3' region with MPE-Fe(II) and DNase I is efficient in
the absence or presence of echinormycin (100 ,um) shows that
this sequence is not bound strongly by echinomycin. Because
the 5' (T-A)6 3' site is resistant to cleavage by nuclease S1 in
the presence of 100 AM echinomycin, this segment is most
likely not denatured. If the structural change that is respon-
sible for purine hyperreactivity to (EtOOC)20 is identical for
purines distal as well as proximal to echinomycin binding
sites, then the data suggest that echinomycin is capable of
inducing Watson-Crick-to-Hoogsteen base-pair transitions
in the absence of other factors such as superhelical torsion
(25), high salt, or multivalent cations. This result appears to
be in disagreement with molecular mechanical calculations
by Kollman and coworkers, who concluded that a Hoogsteen
base-paired structure is unlikely to be found in uncomplexed
DNA with neutral bases, unless specific ion effects can
overcome the significant preference for Watson-Crick pair-
ing due to sugar-phosphate and phosphate-base interactions
(29). However, right-handed Hoogsteen base-paired DNA
was postulated to be a stable structure based on x-ray
analysis of oligonucleotide-triostin A cocrystals (1).
Actinomycin D Bound to DNA Does Not Produce (Et200C)20
Hyperreactivity. Echinomycin binds DNA via bisintercala-
tion and helix unwinding accompanies binding (30). The
question arises as to whether the observed purine hyper-
reactivity to (EtOOC)20 could be due to unwinding of the
DNA helix by the intercalator and not a result of a structural
reorganization such as Hoogsteen base-pairing. Therefore,
another intercalator was screened for its ability to produce
purine hyperreactivity to (EtOOC)20 when bound to DNA.
Actinomycin D, a groove binder-intercalator with G-C spec-
ificity, failed to produce purine hyperreactivity to (EtOOC)20
either proximal or distal to its binding sites even at high-
binding densities. Because actinomycin D is known to un-
wind the DNA helix (31), its failure to induce hyperreactivity
to (EtOOC)20 suggests that (EtOOC)20 responds to a reor-
ganization of purine functional groups rather than to altered
exposure of purine nucleophilic sites because of unwinding of
the B-DNA helix. Furthermore, we find that triostin A
produces a pattern of purine hyperreactivity to (EtOOC)20
nearly identical to that observed for echinomycin. Both
triostin A and echinomycin induce Hoogsteen base-pairing at
their binding sites in solid-state crystal structures (1-3).
CONCLUSION
In solution under physiologically relevant conditions, purines
at the first and/or fourth base-pair positions of echinomycin
binding sites become hyperreactive toward (EtOOC)20 in the
presence of echinomycin. From x-ray analysis of quinoxa-
line-oligonucleotide cocrystals, these same purines were
found to be Hoogsteen base-paired. If this correspondence is
not fortuitous, then (EtOOC)20 detects Hoogsteen base-
pairing in solution.
We are grateful to the American Cancer Society (NP428) and to the
Burroughs Wellcome Company for support.
1. Wang, A. H.-J., Ughetto, G., Quigley, G. J., Hakoshima, T.,
van der Marel, G. A., van Boom, J. H. & Rich, A. (1984)
Science 225, 1115-1121.
2. Ughetto, G., Wang, A. H.-J., Quigley, G. J., van der Marel,
G. A., van Boom, J. H. & Rich, A. (1985) Nucleic Acids Res.
13, 2305-2323.
3. Quigley, G. J., Ughetto, G., van der Marel, G. A., van Boom,
J. H., Wang, A. H.-J. & Rich, A. (1986) Science 232,
1255-1258.
4. Hoogsteen, K. (1959) Acta Crystallogr. 12, 822-823.
5. Watson, J. D. & Crick, F. H. C. (1953) Nature (London) 171,
737-738.
6. Van Dyke, M. W. & Dervan, P. B. (1984) Science 225,
1122-1127.
7. Low, C. M. L., Drew, H. R. & Waring, M. J. (1984) Nucleic
Acids Res. 12, 4865-4879.
8. Low, C. M. L., Olsen, R. K. & Waring, M. J. (1984) FEBS
Lett. 176, 414-420.
9. Herr, W. (1985) Proc. Nati. Acad. Sci. USA 82, 8009-8013.
10. Johnston, B. & Rich, A. (1985) Cell 42, 713-724.
11. Scholten, P. M. & Nordheim, A. (1986) Nucleic Acids Res. 14,
3981-3993.
12. Furlong, J. C. & Lilley, D. M. J. (1986) Nucleic Acids Res. 14,
3995-4007.
13. Leonard, N. J., McDonald, J. J., Henderson, R. L. &
Reichmann, M. E. (1971) Biochemistry 10, 3335-3342.
14. Vincze, A., Henderson, R, E. L., McDonald, J. J. & Leonard,
N. J. (1973) J. Am. Chem. Soc. 95, 2677-2682.
15. Dervan, P. B. (1986) Science 232, 464-471.
16. Beaucage, S. L. & Caruthers, M. H. (1981) Tetrahedron Lett.
22, 1859-1862.
17. Matteucci, M. D. & Caruthers, M. H. (1981) J. Am. Chem.
Soc. 103, 3185-3191.
18. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982) Molecular
Cloning: A Laboratory Manual (Cold Spring Harbor Labora-
tory, Cold Spring Harbor, NY), pp. 250-251.
19. Sutcliffe, J. G. (1979) Cold Spring Harbor Symp. Quant. Biol.
43, 77-90.
20. Tanaka, T. & Weisblum, B. (1975) J. Bacteriol. 121, 354-362.
21. Maxam, A. M. & Gilbert, W. (1980) Methods Enzymol. 65,
499-560.
22. Vogt, V. M. (1973) Eur. J. Biochem. 33, 192-200.
23. Lawley, P. D. & Brookes, P. (1963) Biochem. J. 89, 127-138.
24. Singer, B. (1975) Prog. Nucleic Acids Res. Mol. Biol. 15,
219-284.
25. Pulleyblank, D. E., Haniford, D. B. & Morgan, A. R. (1985)
Cell 42, 271-280.
26. Hertzberg, R. P. & Dervan, P. B. (1984) Biochemistry 23,
3934-3945.
27. Drew, H. R. (1984) J. Mol. Biol. 17, 535-557.
28. Suck, D. & Oefner, C. (1986) Nature (London) 321, 620-625.
29. Singh, U. C., Pattabiraman, N., Langridge, R. & Kollman,
P. A. (1986) Proc. Natl. Acad. Sci. USA 83, 6402-6406.
30. Wakelin, L. P. G. & Waring, M. J. (1976) Biochem. J. 157,
721-740.
31. Waring, M. (1970) J. Mol. Biol. 54, 247-279.
Proc. Natl. Acad. Sci. USA 84 (1987)
